- Exchanges
- BSE, NSE
- Industry
- Pharmaceuticals
- Issue
- Book building
Windlas Biotech IPO
₹407.15
−11.49% on listing
Listing-day close · NSE · 16 Aug 2021 · issue price ₹460
Windlas Biotech’s ₹402 crore IPO was priced at ₹460 a share. It listed on the NSE on 16 Aug 2021 and closed its first day at ₹407.15, down 11.49% on the issue price.
Timeline
- Opens
- Closes
- Allotment
- Refunds
- Shares in demat
- Listing
Issue details
- Issue size
- ₹402 Cr
- Fresh issue
- ₹165 Cr
- Offer for sale
- ₹237 Cr
- Lot size
- 30 shares
- Minimum investment
- ₹13,800
- Face value
- ₹5
- Registrar
- MUFG Intime India
Subscription
| Category | Shares offered | Times subscribed |
|---|---|---|
| Total | — | 14.54× |
Overall, from the basis of allotment.
Financials and valuation
- Market cap (post-issue)
- ₹1,003 Cr
- Promoter holding
- 78.00% → 59.95%
From the offer documents.
Listing
- Listing date
- 16 Aug 2021
- Issue price
- ₹460
- Open
- ₹437.00
- High
- ₹452.00
- Low
- ₹405.00
- Close
- ₹407.15
Listing day on the NSE. The close was −11.49% on the issue price.
WINDLAS share price todayFAQs
When did the Windlas Biotech IPO open and close?
It opened on 4 Aug 2021 and closed on 6 Aug 2021.
What was the Windlas Biotech IPO price?
The price band was ₹448–460 a share. The final issue price was ₹460.
What is the lot size and minimum investment?
One lot is 30 shares, ₹13,800 at ₹460 a share. Retail investors apply in whole lots.
How much did Windlas Biotech raise?
₹402 crore: ₹165 crore of new shares and ₹237 crore offered by existing shareholders.
How many times was the Windlas Biotech IPO subscribed?
14.54 times overall.
How did Windlas Biotech list?
It listed on the NSE on 16 Aug 2021 at ₹437.00 and closed the day at ₹407.15, down 11.49% on the ₹460 issue price.
Who is the registrar of the Windlas Biotech IPO?
MUFG Intime India handles the allotment, refunds and credit of shares.
For information only. Not investment advice or a research report.
Full disclaimerSee how an IPO fits your plan
Armor checks every holding against your goals, risk and timeline.
Get the app